CheckMate 9ER: Subgroup Analyses
CheckMate 9ER: Efficacy of First-line Nivolumab + Cabozantinib vs Sunitinib in Advanced/Metastatic RCC by Baseline Patient Characteristics

Released: June 06, 2021

Activity

Progress
1
Course Completed